LAUSR

Invest Dermatol 2005; 124: 453–456. 14 Kolde G, Frosch PJ, Czarnetzki BM. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol 1984; 83: 175–178. 15 Batkaev E, Olenich I, Chistyakova S, et al. Mastocytosis, diagnosis and treatment. Post Med Ed Herald 2016; 1: 12–16. 16 Mihalik N, Hidvegi B, Harsing J, et al. Clinical observations in cutan mastocytosis. Orv Hetil 2013; 154: 1469–1475. 17 Sotiriou E, Apalla Z, Ioannides D. Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy. Photodermatol Photoimmunol Photomed 2010; 26: 46–47. 18 Srivastava N, Chand S, Singh S. Pseudoxanthomatous mastocytosis. Int J Dermatol 2008; 47: 50–51. 19 Klepper L, Tronnier M. Multiple fibromas in systemic mastocytosis. J Dtsch Dermatol Ges 2005; 3: 363–365. 20 Kinsler VA, Hawk JL, Atherton DJ. Diffuse cutaneous mastocytosis treated with psoralen photochemotherapy: case report and review of the literature. Br J Dermatol 2005; 152: 179–180. 21 Martin LK, Romanelli P, Ahn YS, et al. Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder. Int J Dermatol 2004; 43: 922–924. 22 Mackey S, Pride HB, Tyler WB. Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A. Arch Dermatol 1996; 132: 1429–1430. 23 Smith ML, Orton PW, Chu H, et al. Photochemotherapy of dominant, diffuse, cutaneous mastocytosis. Pediatr Dermatol 1990; 7: 251–255. 24 Kasimov N. PUVA therapy of mastocytosis patients. Vestn Dermatol Venerol 1986; 1: 28–31. 25 James MP. The treatment of urticaria pigmentosa. Clin Exp Dermatol 1982; 7: 311–320. 26 Handler G, Isenberg L, Greaves MW. Concurrence of urticaria pigmentosa and polycythaemia rubra vera. Clin Exp Dermatol 1981; 6: 43–46. 27 Ortonne JP, Forestier JY, Souteyrand P, et al. Dermal mastocytes, histaminaemia, and oral photochemotherapy (author’s transl). Ann Dermatol Venereol 1980; 107: 129–134.